Application

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Patent Number JP-2022037170-A

Publication Year 2022

Application Year 2021

Priority Year 2016

Jurisdiction JP

Status Withdrawn

Inventors

JULIA BOSHUIZEN PAUL PARREN ESTHER BREIJ LOUISE KOOPMAN SATIJN DAVID EDWARD VAN DEN BRINK Dennis VERZIJL ROB DE JONG Riemke VAN DIJKHUIZEN RADERSMA DANIEL PEEPER

Applicants

  1. Genmab (Denmark)
  2. [NORA names: Genmab; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

The present invention provides antibody-drug conjugates (ADCs) for therapeutic use in combination with at least one therapeutic agent, particularly for use in the treatment of melanoma. Antibody-drug conjugates that bind human AXL for use in therapy, particularly in the treatment of melanoma, in combination with one or more MAPK pathway inhibitors (e.g., BRAF inhibitors and/or MEK inhibitors). Gate (ADC). [Selection diagram] Figure 1

Patent Family Records (41)

AXL-specific antibody-drug conjugate for cancer treatment  

Genmab (Denmark), Genmab AS クープマン ルイーズ, クープマン ルイーズ, サテン デイビッド, (...more)

2024, JP-7428680-B2

AXL-specific antibody-drug conjugate for cancer treatment  

Genmab (Denmark), Genmab AS JULIA BOSHUIZEN, DANIEL PEEPER, HENRIK JORN DITZEL, (...more)

2024, JP-2024038480-A

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS JACOBSEN KIRSTINE, DITZEL HENRIK J RN, DITZEL HENRIK JØRN, (...more)

2024, AU-2022259847-B2

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PARREN PAUL, BREIJ ESTHER, (...more)

2024, AU-2017206967-B2

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PARREN PAUL, BREIJ ESTHER, (...more)

2023, US-20230321261-A1

AXL-specific antibody drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS BIRSHUITZER J ¨ 1 RGEN, PARREN PAUL, BREIJ ESTHER, (...more)

2023, CN-116617410-A

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Genmab (Denmark), Genmab AS JULIA BOSHUIZEN, PAUL PARREN, ESTHER BREIJ, (...more)

2022, JP-2022037170-A

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATIONS FOR THE TREATMENT OF CANCER  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2022, CY-1123983-T1

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2022, AU-2022259847-A1

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2022, AU-2016292762-B2

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) PARREN PAUL, DE JONG ROB, PEEPER DANIEL, (...more)

2021, ME-03772-B

AXL-Specific Antibodies-Drug Conjugates for Cancer Treatment  

Genmab (Denmark), Genmab AS クープマン ルイーズ, クープマン ルイーズ, サテン デイビッド, (...more)

2021, JP-6892431-B2

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS JULIA BOSHUIZEN, DANIEL PEEPER, HENRIK JORN DITZEL, (...more)

2021, JP-2021138727-A

Axl-specific antibody-drug conjugates for cancer treatment  

GENMAB AS, Genmab (Denmark)

2021, IL-256790-B

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL SIMON, DITZEL HENRIK J RN, (...more)

2020, US-20200397913-A1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK JORN, (...more)

2020, SI-3319993-T1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2020, RS-60141-B1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark)

2020, PT-3319993-T

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2020, PL-3319993-T3

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2020, LT-3319993-T

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK JOERN, (...more)

2020, HU-E049072-T2

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2020, HR-P20200551-T1

AXL-Specific Antibody-Drug Conjugates for Cancer Treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2020, ES-2784685-T3

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2020, EP-3730520-A1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2020, EP-3319993-B1

AXL-SPECIFIC antibody-drug conjugates for cancer treatment  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, VAN DIJKHUIZEN RADERSMA RIEMKE, PARREN PAUL, (...more)

2020, DK-3319993-T3

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Antoni van Leeuwenhoek Hospital, Genmab (Denmark), Genmab AS, Stichting Het Nederlands Kanker Instituut Boshuizen, Julia, Parren, Paul W H I, Breij, Esther C W, (...more)

2019, US-20190022243-A1

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS クープマン ルイーズ, クープマン ルイーズ, サテン デイビッド, (...more)

2019, JP-2019509257-A

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2018, US-20180326084-A1

AXL-specific antibody-drug conjugates for cancer treatment  

GENMAB A, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK JOERN, (...more)

2018, KR-20180033523-A

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS クープマン ルイーズ, クープマン ルイーズ, サテン デイビッド, (...more)

2018, JP-2018525354-A

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PARREN PAUL, BREIJ ESTHER, (...more)

2018, EP-3402822-A1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2018, EP-3319993-A1

AXL specific antibodies medicine conjugate use for cancer treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PARREN PAUL, BREIJ ESTHER, (...more)

2018, CN-108884165-A

AXL specific antibodies-drug conjugate use for cancer treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK JORN, (...more)

2018, CN-108368171-A

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PARREN PAUL, BREIJ ESTHER, (...more)

2018, AU-2017206967-A1

AXL-specific antibody-drug conjugates for cancer treatment  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2018, AU-2016292762-A1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PARREN PAUL, BREIJ ESTHER, (...more)

2017, WO-2017121877-A1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

GENMAB AS, Genmab (Denmark) BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK J RN, (...more)

2017, WO-2017009258-A1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PARREN PAUL, BREIJ ESTHER, (...more)

2017, CA-3010887-A1

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT  

Genmab (Denmark), Genmab AS BOSHUIZEN JULIA, PEEPER DANIEL, DITZEL HENRIK JORN, (...more)

2017, CA-2991805-A1

Data Provider: Digital Science